Exploring chromosomal abnormalities and genetic changes in uterine smooth muscle tumors

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Modern Pathology

• Publication date

  2016-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/modpathol.2016.107PMID 27363490
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Uterine smooth muscle tumor analysis by comparative genomic hybridization: a useful diagnostic tool in challenging lesions

  2015cited by this paper
• MED12 and HMGA2 mutations: Two independent genetic events in uterine leiomyoma and leiomyosarcoma

  2014cited by this paper
• Genomics of uterine leiomyomas: insights from high-throughput sequencing.

  2014cited by this paper
• Uterine Leiomyomas With Bizarre Nuclei: A Clinicopathologic Study of 59 Cases

  2014cited by this paper
• Cytogenetically normal uterine leiomyomas without MED12-mutations – a source to identify unknown mechanisms of the development of uterine smooth muscle tumors

  2014cited by this paper
• Intracystic papillary carcinoma of the breast: a diagnostic challenge with major clinical impact.

  2014cited by this paper
• WHO classification of tumours of female reproductive organs

  2014cited by this paper
• Molecular analyses of 6 different types of uterine smooth muscle tumors: Emphasis in atypical leiomyoma

  2014cited by this paper
• Chromothripsis in uterine leiomyomas.

  2013cited by this paper
• Uterine Leiomyosarcoma Management, Outcome, and Associated Molecular Biomarkers: A Single Institution’s Experience

  2013cited by this paper
• MED12 mutations in leiomyosarcoma and extrauterine leiomyoma

  2013cited by this paper
• Characterization of uterine leiomyomas by whole-genome sequencing.

  2013cited by this paper
• Chromothripsis in uterine leiomyomas.

  2013cited by this paper
• Molecular evidence for the bi-clonal origin of neuroendocrine tumor derived metastases

  2012cited by this paper
• GREVE: Genomic Recurrent Event ViEwer to assist the identification of patterns across individual cancer samples

  2012cited by this paper
• MED12 Alterations in Both Human Benign and Malignant Uterine Soft Tissue Tumors

  2012cited by this paper
• MED12, the Mediator Complex Subunit 12 Gene, Is Mutated at High Frequency in Uterine Leiomyomas

  2011cited by this paper
• Genetic aberrations in soft tissue leiomyosarcoma.

  2009cited by this paper
• Molecular and immunohistochemical evidence for the origin of uterine leiomyosarcomas from associated leiomyoma and symplastic leiomyoma-like areas

  2009cited by this paper
• Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMP):: A Clinicopathologic Analysis of 16 Cases

  2009cited by this paper
• Distinctive Cytogenetic Profile in Benign Metastasizing Leiomyoma: Pathogenetic Implications

  2007cited by this paper
• The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas

  2007cited by this paper
• Myxoid symplastic leiomyoma of the uterus.

  2006cited by this paper
• Uterine leiomyomata with deletions of Ip represent a distinct cytogenetic subgroup associated with unusual histologic features

  2006cited by this paper
• Uterine Fibroids: The Elephant in the Room

  2005cited by this paper
• Loss of DNA copy number of 10q is associated with aggressive behavior of leiomyosarcomas: a comparative genomic hybridization study.

  2005cited by this paper
• A multiplex PCR predictor for aCGH success of FFPE samples

  2005cited by this paper
• Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling

  2004cited by this paper
• Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999.

  2004cited by this paper
• Multiple uterine angioleiomyomas in a woman presenting with severe menorrhagia.

  2003cited by this paper
• Pathology and Genetics of Tumours of the Breast and Female Genital Organs

  2003cited by this paper
• The retinoblastoma tumour suppressor in development and cancer

  2002cited by this paper
• Leiomyomata: heritability and cytogenetic studies.

  2001cited by this paper
• Frequent loss of heterozygosity for chromosome 10 in uterine leiomyosarcoma in contrast to leiomyoma.

  1999cited by this paper
• Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases.

  1999cited by this paper
• [Uterine leiomyosarcoma with subsequent pregnancy].

  1998cited by this paper
• Leiomyosarcomas of the female genital tract: a clinical and histopathological study.

  1998cited by this paper
• Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality.

  1997cited by this paper
• Analysis of genetic alterations in uterine leiomyomas and leiomyosarcomas by comparative genomic hybridization

  1997cited by this paper
• Histopathologic findings in 107 uterine leiomyomas treated with leuprolide acetate compared with 126 controls.

  1996cited by this paper
• Iipoleiomyomatous tumors of the uterus: A heterogeneous group? Histopathological study of five cases

  1996cited by this paper
• Cellular benign mesenchymal tumors of the uterus. A comparative morphologic and immunohistochemical analysis of 33 highly cellular leiomyomas and six endometrial stromal nodules, two frequently confused tumors.

  1995cited by this paper
• Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata

  1994cited by this paper
• Problematic Uterine Smooth Muscle Neoplasms: A Clinicopathologic Study of 213 Cases

  1994cited by this paper
• Chromosomal abnormalities in leiomyosarcomas.

  1993cited by this paper
• Diffuse, Perinodular, and Other Patterns of Hydropic Degeneration Within and Adjacent to Uterine Leiomyomas: Problems in Differential Diagnosis

  1992cited by this paper
• Chromosome aberrations in uterine smooth muscle tumors: potential diagnostic relevance of cytogenetic instability.

  1990cited by this paper
• Uterine Leiomyomas with Lymphoid Infiltration Simulating Lymphoma. A Report of Seven Cases

  1989cited by this paper
• The epidemiology of sarcomas of the uterus.

  1986cited by this paper
• Apoplectic leiomyomas of the uterus. A clinicopathologic study of five distinctive hemorrhagic leiomyomas associated with oral contraceptive usage.

  1985cited by this paper
• Apoplectic leiomyomas of the uterus: A clinicopathologic study of five distinctive hemorrhagic leiomyomas associated with oral contraceptive usage

  1985cited by this paper
• Neurilemoma-like uterine myomas: an ultrastructural reaffirmation of their non-Schwannian nature.

  1977cited by this paper
• Mesenchymal tumors of the uterus VI. Epithelioid smooth muscle tumors including leiomyoblastoma and clear‐cell leiomyoma. A clinical and pathologic analysis of 26 cases

  1976cited by this paper

• Molecular genetic analysis of pulmonary benign metastasizing leiomyoma and intravenous leiomyomatosis: a comparative study using whole exome sequencing

  2025cites this paper
• Challenges of a tailored immunohistochemistry algorithm for uterine leiomyosarcoma: an integrated analysis of leiomyomas with bizarre nuclei and fumarate hydratase (FH) deficiency

  2025influential citation
• The Morphologic and Molecular Heterogeneity of Fumarate Hydratase-deficient Leiomyomas: Integrative Molecular Profiling of Uterine Smooth Muscle Tumors With Histologic Feature Correlation.

  2025cites this paper
• Methylation Signatures Identify Two Distinct Clusters of Uterine Leiomyosarcoma with Unique Histologic and Clinical Behaviors.

  2025cites this paper
• The Potential Link Between Uterine Fibroids and Cancer Risk: A Comprehensive Review

  2025cites this paper
• Genomic characterization and histologic analysis of uterine leiomyosarcoma arising from leiomyoma with bizarre nuclei

  2024cites this paper
• Genomic profile analysis of leiomyomas with bizarre nuclei and fumarate hydratase deficient leiomyomas: Strengths, weaknesses, and limitations of array‐CGH interpretation

  2024influential citation
• The Effect of Race/Ethnicity and MED12 Mutation on the Expression of Long Non-Coding RNAs in Uterine Leiomyoma and Myometrium

  2024cites this paper
• The Functional Role of the Long Non-Coding RNA LINCMD1 in Leiomyoma Pathogenesis

  2024cites this paper
• Efficient feature extraction and hybrid deep learning for early identification of uterine fibroids in ultrasound images

  2024cites this paper
• Molecular-Based Immunohistochemical Algorithm for Uterine Leiomyosarcoma Diagnosis.

  2023cites this paper
• Differential Expression of MED12-Associated Coding RNA Transcripts in Uterine Leiomyomas

  2023cites this paper
• The Role of Pathogenesis Associated with the Tumor Microclimate in the Differential Diagnosis of Uterine Myocytic Tumors

  2023cites this paper
• Fumarate Hydratase and S-(2-Succinyl)-Cysteine Immunohistochemistry Shows Evidence of Fumarate Hydratase Deficiency in 2% of Uterine Leiomyosarcomas: A Cohort Study of 348 Tumors

  2022influential citation
• Leiomyoma with nuclear atypia: Rare diseases that present a common diagnostic problem.

  2022cites this paper
• Uterine Leiomyosarcoma Associated With Leiomyoma With Bizarre Nuclei: Histology and Genomic Analysis of 2 Cases.

  2022cites this paper
• Loss of Dystrophin is common in Uterine Leiomyosarcoma: a potential biomarker for clinical application.

  2022cites this paper
• Leiomyoma with Bizarre Nuclei: A Current Update

  2022influential citation
• Clinicopathological and molecular characteristics of fumarate-hydratase-deficient uterine smooth muscle tumors: A single-center study of 52 cases.

  2022cites this paper
• Differential Expression of Super-Enhancer-Associated Long Non-coding RNAs in Uterine Leiomyomas

  2022cites this paper
• The landscape of genetic aberrations in myxofibrosarcoma

  2022cites this paper
• Molecular Genetic Basis and Prospects of Gene Therapy of Uterine Leiomyoma

  2021cites this paper
• Frequency of MED12 Mutation in Relation to Tumor and Patient’s Clinical Characteristics: a Meta-analysis

  2021cites this paper
• Emerging Roles of Long Non-coding RNAs in Uterine Leiomyoma Pathogenesis: a Review

  2021cites this paper
• Leiomyoma with Bizarre Nuclei: A Stagnant Precursor to Leiomyosarcoma?

  2021cites this paper
• Long Noncoding RNA MIAT Modulates the Extracellular Matrix Deposition in Leiomyomas by Sponging MiR-29 Family.

  2021cites this paper
• Parity associates with chromosomal damage in uterine leiomyomas

  2021cites this paper
• Cytogenomic Profile of Uterine Leiomyoma: In Vivo vs. In Vitro Comparison

  2021cites this paper
• Integrated histologic and molecular analysis of uterine leiomyosarcoma and 2 benign variants with nuclear atypia

  2020cites this paper
• Targeted sequencing of FH-deficient uterine leiomyomas reveals biallelic inactivating somatic fumarase variants and allows characterization of missense variants

  2019cites this paper
• Understanding Obesity as a Risk Factor for Uterine Tumors Using Drosophila.

  2019cites this paper
• Leiomyoma with Bizarre Nuclei: a Study of 108 Cases Focusing on Clinicopathological Features, Morphology, and Fumarate Hydratase Alterations

  2019cites this paper
• Uterine smooth muscle tumors of unknown malignant potential: A challenging question.

  2019cites this paper
• Combination of MCM2 With Ki67 and p16 Immunohistochemistry Can Distinguish Uterine Leiomyosarcomas

  2019cites this paper
• Transcriptome Analysis of mRNA in Uterine Leiomyoma Using Next-Generation RNA Sequencing.

  2019cites this paper
• Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors

  2018cites this paper
• Immunohistochemical Detection of p16 in Clinical Samples.

  2018cites this paper
• Expression Profiling of lncRNAs, miRNAs, and mRNAs and Their Differential Expression in Leiomyoma Using Next-Generation RNA Sequencing

  2018cites this paper
• The Retinoblastoma Protein

  2018cites this paper
• MED12 mutations and metabolomic changes in uterine leiomyomas

  2017influential citation
• Case Report: A Low-grade Uterine Leiomyosarcoma Showing Multiple Genetic Aberrations Including a Bi-allelic Loss of the Retinoblastoma Gene Locus, as well as Germ-line Uniparental Disomy for Part of the Long Arm of Chromosome 22.

  2017cites this paper
• Leiomyoma With Bizarre Nuclei: A Morphological, Immunohistochemical and Molecular Analysis of 31 Cases

  2017cites this paper
• Expanded molecular profiling of myxofibrosarcoma reveals potentially actionable targets

  2017cites this paper
• Genomic profiling of pelvic genital type leiomyosarcoma in a woman with a germline CHEK2:c.1100delC mutation and a concomitant diagnosis of metastatic invasive ductal breast carcinoma

  2017cites this paper
• Atypical Uterine Smooth Muscle Tumors: A Retrospective Evaluation of Clinical and Pathologic Features

  2017cites this paper
• Fumarate Hydratase Mutations and Alterations in Leiomyoma With Bizarre Nuclei

  2017cites this paper
• THE ROLE OF MED 12 IN TUMORIGENESIS

  2016influential citation
• Molecular classification of uterine leiomyomas by genome-wide methods

  2016cites this paper